U.S. Senator Richard Shelby (R-Ala.), a senior member of the Senate Appropriations Committee, today announced that the U.S. Department of Health and Human Services will award $195,750 to the University of Alabama at Birmingham (UAB) for cancer research.
“UAB is one of the premier medical research facilitates in the nation,” said Shelby. “This funding will help ensure that the university continues to conduct cutting-edge research on one of the most serious diseases facing Americans today. As a cancer survivor myself, I believe that research for new treatments is an important priority for medical research community.”
Specifically, this research will investigate the expression of a recently described family of Fc receptor-like molecules (FCRL) in the most prevalent leukemia in Western countries, B cell chronic lymphocytic leukemia (CLL). Researchers will investigate whether the FCRL2 representative may serve as novel prognostic marker in CLL and replace or supplement current indicators of disease aggressiveness.